Form 8-K - Current report:
SEC Accession No. 0001140361-20-028770
Filing Date
2020-12-18
Accepted
2020-12-17 21:21:11
Documents
14
Period of Report
2020-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10018098_8k.htm   iXBRL 8-K 26566
2 EXHIBIT 99.1 brhc10018098_ex99-1.htm EX-99.1 9443
6 image0.jpg GRAPHIC 11357
  Complete submission text file 0001140361-20-028770.txt   192862

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20201217.xsd EX-101.SCH 4204
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20201217_lab.xml EX-101.LAB 22718
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20201217_pre.xml EX-101.PRE 16222
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10018098_8k_htm.xml XML 4078
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 201397808
SIC: 2834 Pharmaceutical Preparations